Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Prescient Surgical is a medical technology company committed to reducing the burden of surgical site infections (SSIs). They develop and commercialize innovative solutions designed to provide active, intraoperative pathogen removal and irrigation. Their flagship product, CleanCision™, is a novel device that continuously clears and cleanses the surgical site during procedures, aiming to significantly lower infection rates and improve patient recovery. The company focuses on evidence-based approaches to address this critical unmet need in surgery, striving to make surgery safer for patients.
The Sunnyvale headquarters serves as the central hub for research and development, corporate strategy, marketing, sales leadership, clinical affairs, and administrative operations for Prescient Surgical's innovative medical devices.
The facility likely includes modern office spaces, specialized R&D laboratories equipped for medical device development and testing, and collaborative areas designed to foster innovation among its multidisciplinary teams.
The work culture at Prescient Surgical's Sunnyvale HQ is expected to be dynamic, innovative, and mission-driven, with a strong emphasis on scientific rigor, patient safety, and collaboration. Employees are typically passionate about tackling the significant challenge of surgical site infections and contributing to improved healthcare outcomes.
Its Sunnyvale location in the heart of Silicon Valley provides Prescient Surgical with strategic advantages, including access to a highly skilled talent pool in engineering and life sciences, a strong network of suppliers and partners, and a vibrant ecosystem for medical technology innovation and venture capital.
Currently, Prescient Surgical's primary market focus is the United States, where it is working to expand adoption of its CleanCision™ technology. While the company may participate in international medical congresses and explore global partnerships for future expansion, its direct operational presence and commercial activities are concentrated in the U.S. The global relevance of its SSI prevention technology suggests potential for future international market entry through distributors or direct operations as the company grows.
780 N. Mary Avenue
Sunnyvale
CA
USA
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Prescient Surgical' leadership includes:
Prescient Surgical has been backed by several prominent investors over the years, including:
Based on publicly available information as of early 2024, Prescient Surgical has not announced major C-suite executive hires or departures within the last 12 months. The leadership team appears stable, focusing on the commercialization of CleanCision™ and further product development.
Discover the tools Prescient Surgical uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Prescient Surgical likely follows common corporate email naming conventions. A frequently used and probable format is combining the employee's first initial with their last name, followed by '@prescientsurgical.com'. For example, an employee named Jane Doe would likely have an email address like jdoe@prescientsurgical.com. Other variations (e.g., firstname.lastname@) might exist but this is a strong primary candidate for professional communication.
[first_initial][last]@prescientsurgical.com
Format
jcoe@prescientsurgical.com
Example
80%
Success rate
Becker's ASC Review • August 2, 2023
Prescient Surgical announced that its CleanCision™ wound irrigation technology received FDA 510(k) clearance for an expanded indication. This regulatory milestone allows the device to be used in a broader range of surgical procedures, further aiding in the prevention of costly and harmful surgical site infections (SSIs)....more
Business Wire (Press Release) • January 10, 2023
Prescient Surgical successfully closed a $25 million Series C financing round. The company stated the funds will be utilized to accelerate the U.S. commercialization of its innovative CleanCision™ technology and support its mission to prevent surgical site infections....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Prescient Surgical, are just a search away.